References
1. Bharadwaj R, Kumar S. Somnambulism: diagnosis and treatment. Indian
journal of psychiatry 2007; 49: 123.
2 Seeman MV. Sleepwalking, a possible side effect of antipsychotic
medication. Psychiatric Quarterly 2011; 82: 59-67.
3. Gupta R., Das S, Gujar K., Mishra K. K., Gaur, N, & Majid A.
Clinical Practice Guidelines for Sleep Disorders. Indian journal of
psychiatry 2017; 59(Suppl 1), S116–S138. doi:10.4103/0019-5545.196978 .
4. Das S, Gupta R, Dhyani M, Sah D, Maity J. Role of 5HT1A and 5HT2A
receptors and default mode network in olanzapine-induced somnambulism.
Neurology India 2017; 65: 373-4.
5. Tamanna, S, Ullah M I, Pope C. R., Holloman G, & Koch C A.
Quetiapine-induced sleep-related eating disorder-like behavior: a case
series. Journal of medical case reports 2012; 6: 380.
doi:10.1186/1752-1947-6-380.
6. Stallman HM, Kohler M. Prevalence of sleepwalking: a systematic
review and meta-analysis. PloS one 2016; 11: e0164769.
7. Raja M, Raja S. Sleepwalking in four patients treated with
quetiapine. Psychiatria Danubina 2013; 25:80-83.
8. Heathman JC, Neal DW, Thomas CR.Sleep-related eating disorder
associated with quetiapine. Journal of clinical psychopharmacology 2014;
34: 658-60.
9. Hafeez ZH, Kalinowski CM.Somnambulism induced by quetiapine: two case
reports and a review of the literature. CNS Spectrums 2007; 12: 910-2.
10..Mahowald MW, Schenck CH. Insights from studying human sleep
disorders. Nature 2005; 437:1279-85.
11. Kolivakis TT, Margolese HC, Beauclair L, Chouinard G.
Olanzapine-induced somnambulism. Am J Psychiatry 2001;158:1158.
12. Daniel D Lam, Alastair S Garfield, Oliver J Marston, Jill Shaw, Lora
K Heisler. Brain serotonin system in the coordination of food intake and
body weight. Pharmacology Biochemistry and Behavior 2010; Volume 97,
1:84-91.
13. Lee AK, Bishop JR. Pharmacogenetics of leptin in
antipsychotic-associated weight gain and obesity-related complications.
Pharmacogenomics. 2011;12(7):999-1016. doi:10.2217/pgs.11.45